Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2023 Filed Feb 2, 2023 18:30 UTC |
Corcoran AndreaSee Remarks
|
GrantRestricted Stock Units · Derivative | 133,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003607 · doc4.xml · derivative · entry 1 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,100 Underlying: Common Stock · 133,100 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. F2 · derivative.expiration_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 23:35 UTC |
Horga Maria ArantxaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 174,500 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0000899243-23-003621 · doc4.xml · derivative · entry 2 Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,500 Underlying: Common Stock · 174,500 shares Expires 2033-01-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 23:35 UTC |
Horga Maria ArantxaChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 124,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003621 · doc4.xml · derivative · entry 1 Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,600 Underlying: Common Stock · 124,600 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. F2 · derivative.expiration_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 23:28 UTC |
Hammond Janet MJChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 196,600 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0000899243-23-003604 · doc4.xml · derivative · entry 2 Hammond Janet MJ · CIK 0001829899 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,600 Underlying: Common Stock · 196,600 shares Expires 2033-01-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 23:28 UTC |
Hammond Janet MJChief Development Officer
|
GrantRestricted Stock Units · Derivative | 140,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003604 · doc4.xml · derivative · entry 1 Hammond Janet MJ · CIK 0001829899 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,400 Underlying: Common Stock · 140,400 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. F2 · derivative.expiration_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 23:26 UTC |
Vavricka JohnChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $4.63 | $0.00 |
DisclosureSEC source: 0000899243-23-003600 · doc4.xml · derivative · entry 2 Vavricka John · CIK 0001829630 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2033-01-30 F3 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2023 such that the option is fully vested on January 31, 2027. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 23:26 UTC |
Vavricka JohnChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-003600 · doc4.xml · derivative · entry 1 Vavricka John · CIK 0001829630 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. F2 · derivative.expiration_date: The RSUs vest in three (3) equal annual installments on the first three anniversaries of the grant date such that the RSUs are fully vested on January 31, 2026. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 01:00 UTC |
BERGER FRANKLIN MDirector
|
SaleCommon Stock | 16,166 | $5.16 | $83,351.90 |
DisclosureSEC source: 0000899243-22-035942 · doc4.xml · nonDerivative · entry 2 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 778,353 F2 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1000 to $5.2242, inclusive. Read SEC document |
| November 11, 2022 Filed Nov 16, 2022 01:00 UTC |
BERGER FRANKLIN MDirector
|
SaleCommon Stock | 25,500 | $5.15 | $131,332.65 |
DisclosureSEC source: 0000899243-22-035942 · doc4.xml · nonDerivative · entry 1 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 794,519 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.1200 to $5.1947, inclusive. F2 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 23:47 UTC |
Adams Jerome M.Director
|
GrantStock Option (Right to Buy) · Derivative | 61,264 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0000899243-22-023502 · doc4.xml · derivative · entry 1 Adams Jerome M. · CIK 0001863366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,264 Underlying: Common Stock · 61,264 shares Expires 2032-06-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 23:45 UTC |
Polsky BruceDirector
|
GrantStock Option (Right to Buy) · Derivative | 61,264 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0000899243-22-023496 · doc4.xml · derivative · entry 1 Polsky Bruce · CIK 0001508458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,264 Underlying: Common Stock · 61,264 shares Expires 2032-06-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 23:49 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 61,264 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0000899243-22-023505 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,264 Underlying: Common Stock · 61,264 shares Expires 2032-06-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 23:48 UTC |
BERGER FRANKLIN MDirector
|
GrantStock Option (Right to Buy) · Derivative | 61,264 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0000899243-22-023504 · doc4.xml · derivative · entry 1 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,264 Underlying: Common Stock · 61,264 shares Expires 2032-06-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 23:47 UTC |
Murphy Polly A.Director
|
GrantStock Option (Right to Buy) · Derivative | 61,264 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0000899243-22-023501 · doc4.xml · derivative · entry 1 Murphy Polly A. · CIK 0001829248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,264 Underlying: Common Stock · 61,264 shares Expires 2032-06-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 23:45 UTC |
Lucidi BrunoDirector
|
GrantStock Option (Right to Buy) · Derivative | 61,264 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0000899243-22-023498 · doc4.xml · derivative · entry 1 Lucidi Bruno · CIK 0001829622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,264 Underlying: Common Stock · 61,264 shares Expires 2032-06-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 17, 2022, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 17:15 UTC |
Foster WayneEVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0000899243-22-004183 · doc4.xml · derivative · entry 1 Foster Wayne · CIK 0001709769 · EVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2032-01-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 17:15 UTC |
Corcoran AndreaSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 181,000 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0000899243-22-004184 · doc4.xml · derivative · entry 1 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,000 Underlying: Common Stock · 181,000 shares Expires 2032-01-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 17:15 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
GrantStock Option (Right to Buy) · Derivative | 378,033 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0000899243-22-004182 · doc4.xml · derivative · entry 1 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,033 Underlying: Common Stock · 378,033 shares Expires 2032-01-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 22:15 UTC |
Vavricka JohnChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0000899243-22-004186 · doc4.xml · derivative · entry 1 Vavricka John · CIK 0001829630 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2032-01-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 22:15 UTC |
Horga Maria ArantxaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0000899243-22-004185 · doc4.xml · derivative · entry 1 Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2032-01-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 22:15 UTC |
Hammond Janet MJChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 190,000 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0000899243-22-004181 · doc4.xml · derivative · entry 1 Hammond Janet MJ · CIK 0001829899 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2032-01-30 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 02:41 UTC |
Murphy Polly A.Director
|
PurchaseCommon Stock | 12,000 | $8.57 | $102,795.60 |
DisclosureSEC source: 0000899243-21-049313 · doc4.xml · nonDerivative · entry 1 Murphy Polly A. · CIK 0001829248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,295 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 to $8.66, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 21:36 UTC |
Polsky BruceDirector
|
GrantStock Option (Right to Buy) · Derivative | 34,025 | $0.00 Strike: $23.39 | $0.00 |
DisclosureSEC source: 0000899243-21-025049 · doc4.xml · derivative · entry 1 Polsky Bruce · CIK 0001508458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,025 Underlying: Common Stock · 34,025 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 21:35 UTC |
DUNCAN BARBARA GAYLEDirector
|
GrantStock Option (Right to Buy) · Derivative | 34,025 | $0.00 Strike: $23.39 | $0.00 |
DisclosureSEC source: 0000899243-21-025045 · doc4.xml · derivative · entry 1 Duncan Barbara Gayle · CIK 0001353128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,025 Underlying: Common Stock · 34,025 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 21:34 UTC |
BERGER FRANKLIN MDirector
|
GrantStock Option (Right to Buy) · Derivative | 34,025 | $0.00 Strike: $23.39 | $0.00 |
DisclosureSEC source: 0000899243-21-025044 · doc4.xml · derivative · entry 1 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,025 Underlying: Common Stock · 34,025 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 21:30 UTC |
Murphy Polly A.Director
|
GrantStock Option (Right to Buy) · Derivative | 34,025 | $0.00 Strike: $23.39 | $0.00 |
DisclosureSEC source: 0000899243-21-025037 · doc4.xml · derivative · entry 1 Murphy Polly A. · CIK 0001829248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,025 Underlying: Common Stock · 34,025 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 21:36 UTC |
Lucidi BrunoDirector
|
GrantStock Option (Right to Buy) · Derivative | 34,025 | $0.00 Strike: $23.39 | $0.00 |
DisclosureSEC source: 0000899243-21-025047 · doc4.xml · derivative · entry 1 Lucidi Bruno · CIK 0001829622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,025 Underlying: Common Stock · 34,025 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 22:27 UTC |
Adams Jerome M.Director
|
GrantStock Option (Right to Buy) · Derivative | 56,670 | $0.00 Strike: $23.43 | $0.00 |
DisclosureSEC source: 0000899243-21-020247 · doc4.xml · derivative · entry 1 Adams Jerome M. · CIK 0001863366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,670 Underlying: Common Stock · 56,670 shares Expires 2031-05-17 F1 · derivative.exercise_date: The option vests and becomes exercisable in thirty-six (36) equal monthly installments following May 18, 2021. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 16:50 UTC |
Foster WayneSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 71,750 | $0.00 Strike: $73.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003866 · doc4.xml · derivative · entry 1 Foster Wayne · CIK 0001709769 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,750 Underlying: Common Stock · 71,750 shares Expires 2031-01-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 16:56 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
GrantStock Option (Right to Buy) · Derivative | 640,000 | $0.00 Strike: $73.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003873 · doc4.xml · derivative · entry 1 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,000 Underlying: Common Stock · 640,000 shares Expires 2031-01-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 16:52 UTC |
Corcoran AndreaSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 148,850 | $0.00 Strike: $73.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003869 · doc4.xml · derivative · entry 1 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,850 Underlying: Common Stock · 148,850 shares Expires 2031-01-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 21:55 UTC |
Hammond Janet MJChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 160,050 | $0.00 Strike: $73.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003872 · doc4.xml · derivative · entry 1 Hammond Janet MJ · CIK 0001829899 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,050 Underlying: Common Stock · 160,050 shares Expires 2031-01-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 21:51 UTC |
Vavricka JohnChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 117,300 | $0.00 Strike: $73.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003868 · doc4.xml · derivative · entry 1 Vavricka John · CIK 0001829630 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,300 Underlying: Common Stock · 117,300 shares Expires 2031-01-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021. Read SEC document |
| January 29, 2021 Filed Feb 1, 2021 21:51 UTC |
Horga Maria ArantxaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 145,500 | $0.00 Strike: $73.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003867 · doc4.xml · derivative · entry 1 Horga Maria Arantxa · CIK 0001829614 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,500 Underlying: Common Stock · 145,500 shares Expires 2031-01-28 F1 · derivative.exercise_date: The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 29, 2021. Read SEC document |
| November 03, 2020 Filed Nov 3, 2020 20:08 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
ConversionSeries A Convertible Preferred Stock · Derivative | 750,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030329 · doc4.xml · derivative · entry 2 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · Held by JPM Partners LLC Disclosed balance after: 0 Underlying: Common Stock · 750,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 3, 2020 20:08 UTC |
Sommadossi Jean-PierreDirector · President, CEO, and Chairman
|
ConversionCommon Stock | 750,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030329 · doc4.xml · nonDerivative · entry 1 Sommadossi Jean-Pierre · CIK 0001296995 · Director · President, CEO, and Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · Held by JPM Partners LLC Disclosed balance after: 5,925,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 3, 2020 20:08 UTC |
Corcoran AndreaSee Remarks
|
ConversionSeries B Convertible Preferred Stock · Derivative | 33,004 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030330 · doc4.xml · derivative · entry 3 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,004 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 3, 2020 20:08 UTC |
Corcoran AndreaSee Remarks
|
ConversionSeries A Convertible Preferred Stock · Derivative | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030330 · doc4.xml · derivative · entry 2 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 3, 2020 20:08 UTC |
Corcoran AndreaSee Remarks
|
ConversionCommon Stock | 133,004 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030330 · doc4.xml · nonDerivative · entry 1 Corcoran Andrea · CIK 0001296996 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 01:09 UTC |
BERGER FRANKLIN MDirector
|
ConversionSeries D-1 Convertible Preferred Stock · Derivative | 35,474 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 7 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 01:09 UTC |
BERGER FRANKLIN MDirector
|
ConversionSeries D Convertible Preferred Stock · Derivative | 60,540 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 6 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,540 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 01:09 UTC |
BERGER FRANKLIN MDirector
|
ConversionSeries C Convertible Preferred Stock · Derivative | 131,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 5 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 131,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 01:09 UTC |
BERGER FRANKLIN MDirector
|
ConversionSeries B Convertible Preferred Stock · Derivative | 132,014 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 4 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 132,014 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 01:09 UTC |
BERGER FRANKLIN MDirector
|
ConversionSeries A Convertible Preferred Stock · Derivative | 400,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 3 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 01:09 UTC |
BERGER FRANKLIN MDirector
|
PurchaseCommon Stock | 41,666 | $24.00 | $999,984.00 |
DisclosureSEC source: 0000899243-20-030331 · doc4.xml · nonDerivative · entry 2 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 820,019 Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 01:09 UTC |
BERGER FRANKLIN MDirector
|
ConversionCommon Stock | 759,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030331 · doc4.xml · nonDerivative · entry 1 BERGER FRANKLIN M · CIK 0001273885 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 778,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 02:36 UTC |
Hack Andrew A. F.Director
|
ConversionSeries D-1 Convertible Preferred Stock · Derivative | 1,982,469 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030340 · doc4.xml · derivative · entry 4 Hack Andrew A. F. · CIK 0001657434 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Stock · 1,982,469 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F3 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F3 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F3 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F3 · derivative.underlying_shares: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · ownership.nature: Represents shares held directly by Bain Capital Life Sciences Fund II, L.P. ("BCLS II"), BCLS II Investco, LP ("BCLS II Investco") and BCIP Life Sciences Associates, LP ("BCIPLS" and, together with BCLS II and BCLS II Investco, the "Bain Capital Life Sciences Entities"). F2 · ownership.nature: Bain Capital Life Sciences Investors, LLC ("BCLSI") (i) is the ultimate general partner of each of BCLS II and BCLS II Investco, and (ii) governs the investment strategy and decision-making process with respect to investments held by BCIPLS. Dr. Hack is a Managing Director of BCLSI. By virtue of the relationships described in this footnote, Dr. Hack may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. Dr. Hack disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 02:36 UTC |
Hack Andrew A. F.Director
|
ConversionSeries D Convertible Preferred Stock · Derivative | 3,383,190 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030340 · doc4.xml · derivative · entry 3 Hack Andrew A. F. · CIK 0001657434 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Stock · 3,383,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F3 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F3 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F3 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F3 · derivative.underlying_shares: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · ownership.nature: Represents shares held directly by Bain Capital Life Sciences Fund II, L.P. ("BCLS II"), BCLS II Investco, LP ("BCLS II Investco") and BCIP Life Sciences Associates, LP ("BCIPLS" and, together with BCLS II and BCLS II Investco, the "Bain Capital Life Sciences Entities"). F2 · ownership.nature: Bain Capital Life Sciences Investors, LLC ("BCLSI") (i) is the ultimate general partner of each of BCLS II and BCLS II Investco, and (ii) governs the investment strategy and decision-making process with respect to investments held by BCIPLS. Dr. Hack is a Managing Director of BCLSI. By virtue of the relationships described in this footnote, Dr. Hack may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. Dr. Hack disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 02:36 UTC |
Hack Andrew A. F.Director
|
PurchaseCommon Stock | 250,000 | $24.00 | $6,000,000.00 |
DisclosureSEC source: 0000899243-20-030340 · doc4.xml · nonDerivative · entry 2 Hack Andrew A. F. · CIK 0001657434 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,615,659 F4 · shares: On November 3, 2020, BCLS II Investco purchased 250,000 shares of common stock of the Issuer at a price of $24.00 per share, pursuant to an underwritten public offering. F1 · ownership.nature: Represents shares held directly by Bain Capital Life Sciences Fund II, L.P. ("BCLS II"), BCLS II Investco, LP ("BCLS II Investco") and BCIP Life Sciences Associates, LP ("BCIPLS" and, together with BCLS II and BCLS II Investco, the "Bain Capital Life Sciences Entities"). F2 · ownership.nature: Bain Capital Life Sciences Investors, LLC ("BCLSI") (i) is the ultimate general partner of each of BCLS II and BCLS II Investco, and (ii) governs the investment strategy and decision-making process with respect to investments held by BCIPLS. Dr. Hack is a Managing Director of BCLSI. By virtue of the relationships described in this footnote, Dr. Hack may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. Dr. Hack disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 02:36 UTC |
Hack Andrew A. F.Director
|
ConversionCommon Stock | 5,365,659 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-030340 · doc4.xml · nonDerivative · entry 1 Hack Andrew A. F. · CIK 0001657434 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,365,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock. F1 · ownership.nature: Represents shares held directly by Bain Capital Life Sciences Fund II, L.P. ("BCLS II"), BCLS II Investco, LP ("BCLS II Investco") and BCIP Life Sciences Associates, LP ("BCIPLS" and, together with BCLS II and BCLS II Investco, the "Bain Capital Life Sciences Entities"). F2 · ownership.nature: Bain Capital Life Sciences Investors, LLC ("BCLSI") (i) is the ultimate general partner of each of BCLS II and BCLS II Investco, and (ii) governs the investment strategy and decision-making process with respect to investments held by BCIPLS. Dr. Hack is a Managing Director of BCLSI. By virtue of the relationships described in this footnote, Dr. Hack may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. Dr. Hack disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.